trending Market Intelligence /marketintelligence/en/news-insights/trending/urJVXxLa2-2Vxa7pSUkbIg2 content esgSubNav
In This List

Nanobiotix completes €25.1M private placement

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Nanobiotix completes €25.1M private placement

Nanobiotix SA closed a private placement of 1,596,527 new shares priced at €15.75 apiece to raise €25.1 million for the development of its cancer treatment NBTXR3.

The shares issued represent 9.99% of the French company.